These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4397077)

  • 1. Beta-adrenergic blockade in the treatment of left-sided hypertrophic obstructive cardiomyopathy (HOCM).
    Rookmaker WA; Nieveen J; Kruizinga K; Blickman JR
    Acta Med Scand; 1971 May; 189(5):427-31. PubMed ID: 4397077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of beta-receptor blockaders in hypertrophic obstructive cardiomyopathy (HOCM)].
    Kuhn H; Loogen F
    Internist (Berl); 1978 Sep; 19(9):527-31. PubMed ID: 29851
    [No Abstract]   [Full Text] [Related]  

  • 3. Panel discussion: the treatment of hypertrophic cardiomyopathy with beta-adrenergic blockade.
    Postgrad Med J; 1972 Dec; 48(566):791-5. PubMed ID: 4146124
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phonomecanographic study of 3 beta-blockers and d-propranolol in obstructive cardiomyopathy].
    Hitchitz S; Veyrat C; Gourtchiglouian M
    Therapie; 1978; 33(5):599-606. PubMed ID: 33466
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardioselective beta blockade in hypertrophic cardiomyopathy.
    Webb-Peplos MM; Croxson RS; Khanna P; Raphael MJ; Steiner RE; Oakley CM; Goodwin JF
    Acta Cardiol; 1972; ():Suppl 15:263-7. PubMed ID: 4147610
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertrophic obstructive cardiomyopathy in an infant--propranolol therapy for three years.
    Shand DG; Sell CG; Oates JA
    N Engl J Med; 1971 Oct; 285(15):843-4. PubMed ID: 4255121
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-adrenergic blocking agents in hypertrophic cardiomyopathy (HOCM).
    Oakley CM
    Singapore Med J; 1973 Sep; 14(3):408-9. PubMed ID: 4149721
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac impulse in hypertrophic obstructive cardiomyopathy.
    Nagle RE; Boicourt OW; Gillam PM; Mounsey JP
    Br Heart J; 1966 May; 28(3):419-25. PubMed ID: 4222988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Obstructive cardiomyopathy of the left ventricle: prolonged treatment using beta-blockers. Haemodynamic, cineangiocardiographic and echographic study (author's transl)].
    Roudaut R; Page A; Bricaud H; Dallocchio M; Besse P
    Nouv Presse Med; 1979 Jun; 8(27):2286. PubMed ID: 40184
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled clinical trial of beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy (HOCM).
    Hubner P; Ziady G; Lane G; Pridie R; Scales J
    Br Heart J; 1972 Sep; 34(9):963. PubMed ID: 4403883
    [No Abstract]   [Full Text] [Related]  

  • 11. SURGICAL TREATMENT AND POST-OPERATIVE HAEMODYNAMIC STUDIES IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.
    BENTALL HH; CLELAND WP; OAKLEY CM; SHAH PM; STEINER RE; GOODWIN JF
    Br Heart J; 1965 Jul; 27(4):585-94. PubMed ID: 14324118
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of beta adrenergic blockade in the treatment of septic shock.
    Berk JL; Hagen JF; Dunn JM
    Surg Gynecol Obstet; 1970 Jun; 130(6):1025-34. PubMed ID: 4392669
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of the cardiomyopathies.
    Goodwin JF
    Am J Cardiol; 1973 Sep; 32(3):341-51. PubMed ID: 4147410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in left ventricular filling in obstructive cardiomyopathies during long term beta blockade].
    Roudaut R; Page A; Bricaud H; Dallocchio M; Besse P
    Arch Mal Coeur Vaiss; 1980; 73(3):268-75. PubMed ID: 6109524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-adrenergic blockade in congestive cardiomyopathy.
    Wetzel RC
    Lancet; 1980 May; 1(8176):1031. PubMed ID: 6103359
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and mortality of hypertrophic obstructive cardiomyopathy.
    Hardarson T; De la Calzada CS; Curiel R; Goodwin JF
    Lancet; 1973 Dec; 2(7844):1462-7. PubMed ID: 4129311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Classification of primary myocardiopathies according to cineangiographic and hemodynamic data].
    Geschwind H; Nitenberg A; Magnier S; Lemaire F; Bendjaballah H; Laurent D
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1129-44. PubMed ID: 4218728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presumed primary non-obstructive myocardiopathies in children and adolescents].
    Gérard R; Gatau-Pelanchon J; Heuillet G; Amichot JL; Jouve A
    Arch Mal Coeur Vaiss; 1972 Jan; 65(1):51-63. PubMed ID: 4625260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.